Very good :t_up:.
Now as a reward would you prefer
100% of $10
or
50% of $50
Best Wishes
Paper Tiger
Printable View
And I am the first to agree with that, and the first to also alert all on this forum of my change in view when the company failed to deliver on the many expectations and lofty utterances made by the directors and management.
And many of us made money before I changed my view and urged others to get out before the inevitable happened.
The biggest red flag in recent times was the directors not putting any money into the latest capital raising.
http://www.sharetrader.co.nz/showthr...537-Fph/page18
Transparency and disclosure - PEB is the direct opposite of this real Kiwi biomed success story.
TJ: if revenues are growing faster than costs, as you seem to have implied, shouldn't the loss be smaller or the profit bigger?
So the 'brave' underwriters who took stock at 61c are now 30% down the gurgler - 5 months after handing over their $$$ to stop the company from going broke. Their losses on their underlying positions would be worse.
As I have stated before, only buyers left are the 4 institutions/underwriters who have no choice but to buy and hold the price up to protect their reputation and performances. Others are taking the opportunity to exit while those instos have no choice but to buy.
I copped a ban, making a similar observation in June when the sp was over 60 cents, for helping posters save money.
To put it simply-forget the numbers--they have to get a big signup-and if they get it, lots and lots of tests have to be sold,and for that to happen,they have to be perceived as the best,out of the urine tests(which in themselves have to be perceived as worth their salt) until something better comes along.
In terms of changing ones viewpoint on any share--the ability to look at new information and make decisions accordingly(even if that means reversing your stance) is a good,rather than bad thing(one has to be flexible)--The thing to watch out for though, is if it is for the reason of talking up or down which benefit whether one has bought in or looking to buy in rather than the information itself.Or just stubbornly holding and hoping.
This co is not going to make it,as things are now(at least in the form that investors are hoping)
It needs to be funded (covered) by the US gov.Medicare or another large outfit --That is the hope--until then updates and results will not really have much impact IMO
So research really should not be about numbers or %--it should be about anything that will influence whether these coverage's happen.--Then..the next step is numbers